Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
InMed Pharmaceuticals Receives Nasdaq Notification Regarding Minimum Bid Price Compliance
InMed Pharmaceuticals Inc. (NASDAQ: INM) announced it received a notice from Nasdaq regarding its failure to meet the minimum $1.00 bid price requirement for continued listing. The company’s common stock traded below this threshold for 30 consecutive trading days between February 11, 2026, and March 26, 2026. InMed has 180 calendar days to regain compliance, and its shares will continue to trade on The Nasdaq Capital Market under the symbol “INM” while it explores options to cure the deficiency.